Schlumberger (SLB) rose about 5% to roughly $52.10 on October 23, 2026 after third-quarter results showed revenue of $9.45 billion, lifting the shares back above their 200-day average. That reverses the negative reading of October 20. The balance of evidence is now even, with low conviction (1 of 4 points). The weekly uptrend is intact, but the stock is still under its 50-day average and trails the energy sector.
Why it matters
The quarter showed an operation improving from the one before it. Revenue rose 5% sequentially and 6% from a year earlier, and adjusted EBITDA of $2.07 billion was up 9% on the quarter, according to the SEC filing. Earnings per share excluding charges were $0.64, up 16% sequentially but still 7% below last year. GAAP EPS of $0.49 fell 6% on the quarter and 2% on the year. The business is recovering from a soft patch, but profit per share has not yet caught up with last year.
The market's response was large and mostly the stock's own. Shares gained 5.1% on the day and 5.2% over five days, while the S&P 500 fell 0.4% and XLE, the energy sector fund, rose 1.1%. That leaves about 4.2 points of outperformance against the sector over five days, which is what an earnings reaction looks like. The jump recovers ground more than it breaks new ground. The September 22 peak close was $52.12, so the stock is only back to that level. Over the past month it is up just 0.4% while XLE has gained 10.6%, and it remains 13.3% below its 52-week high of $60.10. Mid-session volume is about 59% below its 20-day average. That is a partial-day figure, but heavy buying has not shown up so far.
No published debate about SLB turned up in the news feed, so the argument has to be inferred from the numbers. The constructive side points to the sequential gains in revenue, EBITDA and earnings, and to a demand story such as Venezuela seeking U.S. investment to repair its oil fields, as The Wall Street Journal reports. The skeptical side points to the 7% year-on-year drop in adjusted EPS and to the stock lagging XLE by 7.5% over 50 days. Investors have been rewarding oil producers more than the companies that serve them, and one good quarter has not yet changed that.
On valuation, 29 analysts rate the stock a buy, with a mean price target of $62.28, a low of $43 and a high of $75. The price is 16.3% below that mean, and the mean sits above the 52-week high. The wide spread, with the lowest target below today's price, shows analysts are not agreed on how far the recovery runs. The market value is about $77.3 billion.
What the evidence says
On the long term, the thesis has gone from broken to weakened. The October 20 report called the direction negative with high conviction. It had the price below its 40-week average and said the picture would change on a weekly close above $51.13, the 200-day average. Price is now above both the 40-week average and the 200-day average, which has since drifted to $51.25. Because today is Friday, the weekly close is only set at the end of the session. The stock is up 35.7% for the year, so the larger advance is intact. But it has gone nowhere over six months (down 4.8%) and is consolidating well below the $60.10 high.
For the next 2 to 6 weeks, the balance of evidence is even, and conviction is low at 1 of 4 points. The weekly trend is up, but the stock is in a pullback against it that is not yet stretched, with RSI at 57.8. Strength against the S&P 500 is marginal, at +0.3% over 50 days. The stock is below its 50-day average at $52.45 and below its 10-week average, and it lags the sector. Nothing lines up with the weekly trend, so no direction earns more weight than the other.
The strongest case against an even reading is the positive one: the stock has reclaimed the 200-day average, sits above the 40-week line, jumped on earnings and is outpacing the market. Across 91 past cases of reclaiming the 200-day average, 59.3% were higher a month later, slightly below the 61.8% typical for any month, with a median move of +1.69%. That is no edge. The 50-day average is still overhead, the sector has run far ahead of the stock, and the volume so far is thin. That is why conviction is not higher.
Levels that matter
The structure holds above $51.25, the 200-day average, and the first crack comes on a break below it. The trend itself ends below $50.5, a swing zone, with the $50 round number just beneath it and $48.62 the next support. Those levels matter because they are where buyers stepped in before and where the stock has just regained its footing.
The breakout level is a daily close above $52.45, the 50-day average, on volume above its 20-day average. From there the first target is $52.97 and the second is $53.86, against a stop at $50.88, which is the 200-day average less a quarter of a day's typical range. That gives reward-to-risk of 0.3 to 1 for the first target and 0.9 to 1 for the second. The math does not reach 3 to 1. Only a target out near the $60 round number would clear that bar, and it sits far beyond the nearer swing zones.
What would change the picture
A weekly close below $50.5 would hand the picture back to the negative side. It would mean the 200-day average has failed as support and the earnings reaction has been fully erased. The non-price fact that would do it is evidence that the improvement in the third quarter is stalling, such as softer outlook commentary from SLB or signs that customers are trimming spending plans. That would confirm the year-on-year earnings gap is the real story and not the sequential recovery.
What to watch
- Earnings: SLB reported today, October 23, and the next report date is not yet in the data. The number to track is adjusted EPS, now $0.64 and 7% below a year ago. It needs to turn up on the year.
- Sector: XLE is up 10.6% over a month while SLB is up 0.4%, so oil-price moves and the sector's direction can move the stock before any company news. Watch also the oil market's logistics, including Reuters reporting that Saudi Aramco is weighing discounts of around $9 a barrel on Oman crude to offset record freight rates.
- Valuation: the mean price target of $62.28 is 16.3% above the price, but targets range from $43 to $75, so consensus offers little precision.